Rethinking how cancer cells evade targeted therapy
Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.
Dec 20, 2022
0
43
